Recent Company News

• 09:55 AM ET Jul 30, 2026
  

  Transcript Intelligence: DSM-Firmenich Q2 Earnings Guidance

• 09:55 AM ET Jul 30, 2026
  

  Transcript Intelligence: DSM-Firmenich Q2 Earnings Themes

• 09:54 AM ET Jul 30, 2026
  

  Transcript Intelligence: DSM-Firmenich Q2 Earnings Q&A

• 04:42 AM ET Jul 30, 2026
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 03:56 AM ET Jul 30, 2026
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (55 total)

• 02:59 AM ET Jul 30, 2026
  

  StreetAccount Summary - European pre-market trading update

• 01:15 AM ET Jul 30, 2026
  

  StreetAccount Metrics Recap - DSM-Firmenich Q2 Earnings (€83.38, 0.00)

• 01:13 AM ET Jul 30, 2026
  

  DSM-Firmenich reports Q2 adjusted EBITDA €466M vs consensus €452.0M; FY LfL sales growth to be at the higher end of 2-4% target (€83.38, 0.00)

• 06:13 AM ET Jul 29, 2026
  

  StreetAccount Consensus Metrics Preview - DSM-Firmenich Q2 Earnings (€83.62, +0.18)

• 07:16 AM ET Jul 22, 2026
  

  Bernstein initiates DSFIR.NA, GIVN.SW, KRZ.ID, and SY1.GR (21-Jul, timing uncertain)